Healthcare -
Biotechnology - NASDAQ - US
$ 3.5
-0.293 %
$ 670 M
Market Cap
-8.29
P/E
ABUS - OPERATING INCOME
Operating Income ABUS - Arbutus Biopharma Corporation
-76.3 M
LAST VALUE
-7.98%
2 YEAR CAGR
11.93%
5 YEAR CAGR
-8.75%
10 YEAR CAGR